Skip to main content

Gout

      Rheumatology RoundUp: EULAR 2025
      Nurse-Led Treat-to-Target Clinics
      • EurekAlert!
      New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits that nurse-led care can bring for both patients and healthcare systems.
      1st #recommendations for
      #Hemochromatosis #arthropathy

      #psuedogout
      #CPPD
      #calcium #pyrophosphate #arthritis

      #EULAR20

      Janet Pope Janetbirdope

      10 months ago
      1st #recommendations for #Hemochromatosis #arthropathy #psuedogout #CPPD #calcium #pyrophosphate #arthritis #EULAR2025 #Recommenadations II @RheumNow @eular_org https://t.co/AnE4T2wYoa
      URAT1 inhibitors look like the way to go in Gout!

      Presented in multiple abstracts at #EULAR2025

      Pozdeutinurad Ph2 lon

      Aurelie Najm AurelieRheumo

      10 months ago
      URAT1 inhibitors look like the way to go in Gout! Presented in multiple abstracts at #EULAR2025 Pozdeutinurad Ph2 long term safety data chronic gouty arthritis + tophi OP0300 Ph3 RCT of Ruzinurad in hyperuricemia/primary gout OP0302 Ph 2b RCT of SAP-001 Refractory Gout +/-
      🦵🏻SAP-001, a novel uricosuric targeting a non-URAT1 renal transporter, lowered sUA <6 mg/dL in up to 79% of p

      Mrinalini Dey DrMiniDey

      10 months ago
      🦵🏻SAP-001, a novel uricosuric targeting a non-URAT1 renal transporter, lowered sUA <6 mg/dL in up to 79% of patients with refractory #gout on b/g xanthine oxidase inhibitor. >50% on 60 mg/day reached sUA <3 mg/dL. 💊Potential new oral ULT option. @RheumNow #EULAR2025 #LB0008 https://t.co/dfY1V5sHSh
      What do we do when we see Rx signed of CPPD in RA pts? Do these pts have different trajectory?

      Rx Retro study 388 patie

      Aurelie Najm AurelieRheumo

      10 months ago
      What do we do when we see Rx signed of CPPD in RA pts? Do these pts have different trajectory? Rx Retro study 388 patients RA 18% at least one sign CPPD ns diff between seeonegative and seropositive pts RA+CPPD group was -older -higher comorbidity score -more likely to be https://t.co/DaW5DZoDzF
      New ideas in gout management
      • EurekAlert!
      Gout flares are associated with cardiovascular events. Treating gout to target serum urate level prevents flares, but whether such treatment can also prevent cardiovascular events is unknown.
      EULAR Daily Recap: Day 3
      T2T in #gout w serum #uric #acid / #urate target

      SAVES LIVES

      Study of achievement of target 🎯
      ⬇️CVE and death

      Janet Pope Janetbirdope

      10 months 1 week ago
      T2T in #gout w serum #uric #acid / #urate target SAVES LIVES Study of achievement of target 🎯 ⬇️CVE and death If not achieving Urate <360 T2T also reduced baseline #SUA #EULAR2025 @rheumnow abst#OP0005 https://t.co/ePchJ4vqnU
      Wednesday was Day One at EULAR 2025 in Barcelona. Thousands from around the world gathered, eager to reunite at this international educational forum. Below are a few of my favorites from Day 1.
      What’s worse for infection in GCA: tail end steroid taper, or a JAK inhibitor?

      This is exactly SELECT-GCA in the seco

      David Liew drdavidliew

      10 months 1 week ago
      What’s worse for infection in GCA: tail end steroid taper, or a JAK inhibitor? This is exactly SELECT-GCA in the second 6mo. What happened? upa skews better on serious infection, worse on HZ JAKi might have infection risk, but not like steroids. OP0057 #EULAR2025 @RheumNow https://t.co/FigxviOW3e
      Can lowering serum urate also lower CV risk? In >116k patients w/ #gout, achieving SU <360 µmol/L in 12m ↓ 5yr

      Mrinalini Dey DrMiniDey

      10 months 1 week ago
      Can lowering serum urate also lower CV risk? In >116k patients w/ #gout, achieving SU <360 µmol/L in 12m ↓ 5yr MACE risk (HR 0.89, pooled Δsurvival +1.4%). Greater effect in >65s. Gout management = CV prevention? @RheumNow #EULAR2025 #OP0005 https://t.co/NRAerUBemN
      ×